Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Compliance Corner: First Impressions Count During FDA Inspections, Ex-Investigators Say

Executive Summary

Referring to a US FDA investigator as an "inspector" might not seem like a big deal, but it is – and doing so can taint an inspection right from the start, industry insider Ricki Chase says. The former director of FDA’s Investigations Branch gives other pointers – including avoiding snatching investigator credentials and asking investigators if they're at the company to inspect the cafeteria. Another former FDA Investigations Branch director, David Chesney, chimes in, offering advice to ensure the best first impression.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT104318

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel